Mimedx (MDXG) Net Margin (QoQ) (2011 - 2024)

Mimedx (MDXG) Net Margin (QoQ) (2011 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Mimedx 635.35 Mn 475.58 Mn 41.62 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 -137.00
Sep 30, 2024 -1,083.00
Jun 30, 2024 951.00
Mar 31, 2024 -4,093.00
Dec 31, 2023 4,298.00
Sep 30, 2023 -61.00
Jun 30, 2023 1,432.00
Mar 31, 2023 -1,600.00
Dec 31, 2022 2,585.00
Sep 30, 2022 377.00
Jun 30, 2022 182.00
Mar 31, 2022 -1,775.00
Dec 31, 2021 345.00
Sep 30, 2021 -140.00
Jun 30, 2021 1,162.00
Mar 31, 2021 992.00
Dec 31, 2020 5,449.00
Sep 30, 2020 -6,506.00
Jun 30, 2020 -797.00
Mar 31, 2020 198.00